No Detail Found!

Tacrolimus ointment as monotherapy in management of moderate to severerefractory vernal keratoconjunctivitis.

Author(s)
Neelam Manzoor PUMHS SHAHEED BENAZIRABAD. Sindh Pakistan
Parus Saleem PUMHS SHAHEED BENAZIRABAD. Sindh Pakistan
Khan Muhammad Nangrejo PUMHS SHAHEED BENAZIRABAD. Sindh Pakistan
Amjad Sahito PUMHS SHAHEED BENAZIRABAD. Sindh Pakistan
Ayesha khan PUMHS SHAHEED BENAZIRABAD. Sindh Pakistan
Sikandar Mirza PUMHS SHAHEED BENAZIRABAD. Sindh Pakistan
Abstract
Introduction: In the modern era of industrialization and global seasonal change, human health has been adversely affected. One of its sequels is ocular allergy. Objective: To evaluate the efficacy and safety of (0.03%) tacrolimus skin ointment in patients with moderate to severe refractory vernal keratoconjunctivitis (VKC). Study Design: Prospective interventional study. Setting & Duration: Ophthalmology outpatient department (OPD) Peoples University of Medical and Health Sciences from 16 February 2019 to 16 August 2021. Material &Methods: 200 patients suffering from moderate to severe VKC were selected, based on TSSS (Total subjective scoring system) and TOSS total objective scoring system). The study participants were separated into 2 groups (100 each) withtreatment group receiving0.03% Tacrolimus ointment while the other receiving conventional therapy. To determine the effectiveness (measured by the change mostly in clinical condition), a randomised clinical investigation was carried out and safety (safe treatment from development of any complications or side effects) of Tacrolimus ointment in comparison with conventional therapy. Result: It was observed that 73% patients had tarsal form of VKC, 24% had limbal and 3% had mixed (both) types of disease. Every one of the patients had complete subjective symptom severity ratings (TSSS) and total objective ocular severity scores (TOSS) which ranged among 2 & 3. Treatment with either 0.03% Tacrolimus or conventional group was found to be effective in eradicating the symptoms of VKC measured by TSSS scores. Conclusion: Among the medical therapies used in this study it is found that, Tacrolimus ointment 0.03% was more nontoxic & actual in eradicating the severity of signs and symptoms of the vernal keratoconjunctivitis evident by the TSSS and TOSS scores. (ASM allergic systemic manifestations)rhinitis, asthma and eczema)
Publication Details
Page(s) 58-67
Published Journal: journal of Peoples University of medical and Health Sciences, Pakistan., Volume: 13, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
Tacrolimus, Vernal keratoconjunctivitis, TOSS (total objective ocular scoring system) ASM (Associated Syestemic manifestation), TSSS (total subjective scoring system)
0

Citations

0

Downloads

44

Views